1 Department of Pediatrics/Division of Emergency Medicine, Children's Hospital of Michigan, Detroit
2 Department of Pediatrics/Division of Emergency Medicine, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit
Objective. Recent studies have demonstrated that a single intramuscular injection of dexamethasone (0.6 mg/kg) shortens the duration and severity of illness in hospitalized patients with acute viral laryngotracheitis (croup). Our objective was to determine if dexamethasone has a role in the outpatient management of patients with acute viral croup of moderate severity.
Methods. Patients, 6 months to 5 years of age, who came to the emergency department (ED) with acute viral croup, a croup score of at least 2 (range 0 to 17), and a disposition of discharge were randomized in a double-blind fashion to receive a single intramuscular injection of dexamethasone, 0.6 mg/kg, or an equal volume of normal saline before discharge from the ED. Patients were excluded if they had any structural abnormalities, had received any steroids in the preceding 24 hours, or if they required
-agonist therapy, more than one racemic epinephrine treatment, or hospitalization. Patients were followed up by telephone 24 hours and 7 to 10 days after discharge to determine whether additional medical attention was sought for perceived lack of improvement or worsening of symptoms. Secondary outcome included the parents' perception of how the child was doing at 24 hours, based on a 4-point ordinal scale: worse (1), same (2), improved (3), symptoms resolved (4), and the number of days it took for complete recovery.
Results. Of the 38 patients comprising the study group, 19 received dexamethasone. The median age was 19 months (range 6 to 66 months), and median pretreatment croup score was 3 (range 2 to 5) for both groups. The number of patients requiring racemic epinephrine was similar in both groups. Five patients sought additional medical attention within 48 hours. Four of the five patients had received placebo (21% of the placebo group) and one had received dexamethasone (5% of the steroid group) (not statistically significant). At the 24-hour telephone follow-up, significantly more patients in the dexamethasone group had a score consistent with improvement compared with placebo (84% vs 42%, P = .003). There was no difference in the number of days for symptoms to completely resolve between the two groups.
Conclusion. The use of dexamethasone in the outpatient management of viral croup was associated with a reduction in severity of illness within 24 hours after treatment. Patients with viral croup of moderate severity should be considered as candidates for the use of dexamethasone before discharge from the ED.
Submitted on January 17, 1995
This article has been cited by other articles:
![]() |
S. McGee and J. Hirschmann Use of Corticosteroids in Treating Infectious Diseases Arch Intern Med, May 26, 2008; 168(10): 1034 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Luria, J. A. Gonzalez-del-Rey, G. A. DiGiulio, C. M. McAneney, J. J. Olson, and R. M. Ruddy Effectiveness of Oral or Nebulized Dexamethasone for Children With Mild Croup Arch Pediatr Adolesc Med, December 1, 2001; 155(12): 1340 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Rittichier and C. A. Ledwith Outpatient Treatment of Moderate Croup With Dexamethasone: Intramuscular Versus Oral Dosing Pediatrics, December 1, 2000; 106(6): 1344 - 1348. [Abstract] [Full Text] |
||||
![]() |
Corticosteroids for croup DTB, March 1, 2000; 38(3): 22 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P Klassen, A. J Tillett, J. D M Gould, C. Cates, S Jothimurugan, Z. Hassan, and M Silverman Effectiveness of glucocorticoids in treating croup BMJ, December 11, 1999; 319(7224): 1577a - 1577. [Full Text] |
||||
![]() |
J. C. Bernini, Z. R. Rogers, E. S. Sandler, J. S. Reisch, C. T. Quinn, and G. R. Buchanan Beneficial Effect of Intravenous Dexamethasone in Children With Mild to Moderately Severe Acute Chest Syndrome Complicating Sickle Cell Disease Blood, November 1, 1998; 92(9): 3082 - 3089. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Jaffe The Treatment of Croup with Glucocorticoids N. Engl. J. Med., August 20, 1998; 339(8): 553 - 555. [Full Text] |
||||
![]() |
T. P. Klassen, W. R. Craig, D. Moher, M. H. Osmond, H. Pasterkamp, T. Sutcliffe, L. K. Watters, and P. C. Rowe Nebulized Budesonide and Oral Dexamethasone for Treatment of Croup: A Randomized Controlled Trial JAMA, May 27, 1998; 279(20): 1629 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
G C Geelhoed, J Turner, and W B G Macdonald Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial BMJ, July 20, 1996; 313(7050): 140 - 142. [Abstract] [Full Text] |
||||
![]() |
STEROIDS FOR OUTPATIENT TREATMENT OF CROUP Journal Watch (General), August 18, 1995; 1995(818): 5 - 5. [Full Text] |
||||